OCEA (Ocean Biomedical) Gross Margin %: 0.00% (As of Mar. 2025)

What is Ocean Biomedical Gross Margin %?

Ocean Biomedical OCEA -75.00% Gross Margin % is 0.00% as of Mar. 2025.

Gross Margin % is calculated as gross profit divided by its revenue. Ocean Biomedical's Gross Profit for the three months ended in Mar. 2025 was $0.00 Mil. Ocean Biomedical's Revenue for the three months ended in Mar. 2025 was $0.00 Mil. Therefore, Ocean Biomedical's Gross Margin % for the quarter that ended in Mar. 2025 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

The historical rank and industry rank for Ocean Biomedical's Gross Margin % or its related term are showing as below:

OCEA's Gross Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: 60.9
* Ranked among companies with meaningful Gross Margin % only.

Ocean Biomedical had a gross margin of N/A% for the quarter that ended in Mar. 2025 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Ocean Biomedical was 0.00% per year.

Ocean Biomedical (OTCPK:OCEA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ocean Biomedical had a gross margin of N/A% for the quarter that ended in Mar. 2025 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Ocean Biomedical Gross Margin % Related Terms

Ocean Biomedical Gross Margin % Historical Data

* Premium members only.

The historical data trend for Ocean Biomedical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocean Biomedical Gross Margin % Chart

Ocean Biomedical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross Margin %

Get a 7-Day Free Trial

0.00

Ocean Biomedical Quarterly Data
	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Gross Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

OCEA vs SIGY, ENDV, SCPX: Gross Margin % Comparison

For the Biotechnology subindustry, Ocean Biomedical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocean Biomedical Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocean Biomedical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ocean Biomedical's Gross Margin % falls into.

Save Embed

Ocean Biomedical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Ocean Biomedical's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )	=	Gross Profit (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

Ocean Biomedical's Gross Margin for the quarter that ended in Mar. 2025 is calculated as

Gross Margin % (Q: Mar. 2025 )	=	Gross Profit (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →

What does a Gross Margin % of 0.00% mean?

Ocean Biomedical (OCEA) has a Gross Margin % of 0.00% as of Mar. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Ocean Biomedical and its competitors.

Is Ocean Biomedical's Gross Margin % too high?

Ocean Biomedical's current Gross Margin % is 0.00%.

How does Ocean Biomedical's Gross Margin % compare to SIGY and ENDV?

Ocean Biomedical's Gross Margin % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Gross Margin % is 60.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Gross Margin % for a Biotechnology company?

The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Gross Margin % mean?

A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Ocean Biomedical and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocean Biomedical's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Ocean Biomedical stock overvalued right now?

Ocean Biomedical (OCEA) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Gross Margin % calculated?

Gross Margin % is calculated from a company's financial statements. For Ocean Biomedical (OCEA), the current Gross Margin % is 0.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ocean Biomedical Business Description

Industry Healthcare Biotechnology

Comparable Companies SIGY ENDV SCPX RGBP CNBX WINT VINC HEPA ATXI RMTG VRTX REGN XBRU:UCB XKRX:207940 XBRU:ARGX ASX:CSL ALNY ONC XKRX:068270 INSM

Address 55 Claverick Street, Room 325, Providence, RI, USA, 02903

Website https://www.oceanbiomedical.com

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.